Virus-induced senescence is a driver and therapeutic target in COVID-19Soyoung Lee, Clemens A. Schmitt, Séverine Kunz et al.|Nature|2021Cited by 344
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label StudyFrancesco Di Pierro, Sagheer Ahmed, Giuseppe Derosa et al.|International Journal of General Medicine|2021Cited by 183
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical TrialFrancesco Di Pierro, Saeed Khan, Somia Iqtadar et al.|International Journal of General Medicine|2021Cited by 177
Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate CancerAmjad Khan, Arun Sreekumar|Molecular & Cellular Proteomics|2009Cited by 124
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trialFrancesco Di Pierro, Nicola Zerbinati, Amjad Khan et al.|Frontiers in Pharmacology|2023Cited by 54